Test Drive Our Technology
APIJECT ANNOUNCES PROOF-OF-CONCEPT in BLOW-FILL-SEAL AT ORLANDO TECHNOLOGY DEVELOPMENT CENTER
Orlando, FL, February 28, 2024?– ApiJect Systems, Corp., a medical technology public-benefit corporation, announced it has added product development capabilities, including Proof-of-Concept studies that use as little as 8 liters of vaccine or drug product to test compatibility in Blow-Fill-Seal (BFS) using ApiJect prefilled injector technology. Higher volumes may be needed based on the specific requirements of the drug product.
“We are delighted to make it easier than ever for pharmaceutical companies to test their drug product while realizing the benefits of the Prefilled ApiJect Injector,” said Bo Kowalczyk, Chief Commercial Officer, ApiJect. “With this added capability, biopharmaceutical development and manufacturing companies can provide us with a small amount of vaccine or drug product to test whether it can be reliably filled in BFS using ApiJect technology. We are excited to offer current and prospective customers Proof-of-Concept to “test drive” our technology.”
The ApiJect Technology Development Center (ATDC) in Oakland, Florida is undergoing expansion from 16,000 sq. ft. to 32,000 sq. ft. The center is equipped with various BFS machines, prototype mold designs and creation capabilities, BFS container testing, mold modification and maintenance, needle hub fitting, prefilled injector testing, feasibility filling, and stability foil wrapping.
Making Prefilled Drug Delivery Possible for Even More Injectables
Want to learn more? Connect with us at DCAT Week!
Benjamin Royal Sonesta, Suite 301, New York, NY
领英推荐
Upcoming Events and Presentations
World Vaccine Congress, Washington, DC - Apr 1-4, 2024
Prefilled Syringes & Injectable Drug Devices EC, Boston, MA - Apr 22-24, 2024
Injectable Drug Delivery, London, UK - May 8-9, 2024
Med-Tech Innovation Expo, Birmingham, UK - Jun 5-6, 2024
Prefilled Syringes West Coast, San Diego, CA - Jun 10-11, 2024
Contract Pharma Outsourcing, New Brunswick, NJ - Sep 21-22, 2024
CPHI, Milan, Italy - Oct 8-10, 2024
PDA Universe of Prefilled Syringes, Phoenix, AZ - Oct 22-23, 2024
World Vaccine Congress EU, Barcelona, Spain - Oct 28-31, 2024
PODD: Partnerships in Drug Delivery, Boston, MA - Oct 28-29, 2024
Accelerate your drug or vaccine development with ApiJect Prefilled Injector technology, enabling streamlined Proof-of-Concept studies with as little as 8 liters of product for BFS compatibility testing.?